Wednesday 17 April 2019
Cerbios-Pharma Investing in New High-Potency AP...
Cerbios-Pharma SA is expanding its high-potency API (HPAPI) production and conjugation capabilities. Gabriel Haering, Chief Executive Officer, Cerbios-Pharma SA, outlined the expansion at the DCAT Week ’19 Member Company Announcement Forum, which was held March 18, 2019 in New...
News HighlightView all news
Tuesday 17 September 2019
Event HighlightView all events
Services View all services
Chemical APIs and HPAIs Contract Development an...
With a long-term expertise in the development and industrial scale manufacturing of APIs and its know-how in handling High Potency Active Ingredients (HPAIs), Cerbios is the ideal and reliable...
View all competencies